These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

571 related items for PubMed ID: 16707469

  • 1. Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation.
    Imre G, Gekeler V, Leja A, Beckers T, Boehm M.
    Cancer Res; 2006 May 15; 66(10):5409-18. PubMed ID: 16707469
    [Abstract] [Full Text] [Related]

  • 2. Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.
    Rundall BK, Denlinger CE, Jones DR.
    Surgery; 2004 Aug 15; 136(2):416-25. PubMed ID: 15300209
    [Abstract] [Full Text] [Related]

  • 3. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG, Chaturvedi MM, Aggarwal BB.
    Oncogene; 2007 Mar 01; 26(10):1385-97. PubMed ID: 16953224
    [Abstract] [Full Text] [Related]

  • 4. Magnolol suppresses NF-kappaB activation and NF-kappaB regulated gene expression through inhibition of IkappaB kinase activation.
    Tse AK, Wan CK, Zhu GY, Shen XL, Cheung HY, Yang M, Fong WF.
    Mol Immunol; 2007 Apr 01; 44(10):2647-58. PubMed ID: 17240450
    [Abstract] [Full Text] [Related]

  • 5. Proteasome inhibition sensitizes non-small cell lung cancer to histone deacetylase inhibitor-induced apoptosis through the generation of reactive oxygen species.
    Denlinger CE, Rundall BK, Jones DR.
    J Thorac Cardiovasc Surg; 2004 Nov 01; 128(5):740-8. PubMed ID: 15514602
    [Abstract] [Full Text] [Related]

  • 6. Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.
    Berman KS, Verma UN, Harburg G, Minna JD, Cobb MH, Gaynor RB.
    Clin Cancer Res; 2002 Feb 01; 8(2):354-60. PubMed ID: 11839649
    [Abstract] [Full Text] [Related]

  • 7. Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.
    Hu J, Colburn NH.
    Mol Cancer Res; 2005 Feb 01; 3(2):100-9. PubMed ID: 15755876
    [Abstract] [Full Text] [Related]

  • 8. FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of nuclear factor-kappaB.
    Lan CC, Yu HS, Wu CS, Kuo HY, Chai CY, Chen GS.
    Br J Dermatol; 2005 Oct 01; 153(4):725-32. PubMed ID: 16181452
    [Abstract] [Full Text] [Related]

  • 9. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Matsumoto G, Namekawa J, Muta M, Nakamura T, Bando H, Tohyama K, Toi M, Umezawa K.
    Clin Cancer Res; 2005 Feb 01; 11(3):1287-93. PubMed ID: 15709200
    [Abstract] [Full Text] [Related]

  • 10. Diosgenin inhibits osteoclastogenesis, invasion, and proliferation through the downregulation of Akt, I kappa B kinase activation and NF-kappa B-regulated gene expression.
    Shishodia S, Aggarwal BB.
    Oncogene; 2006 Mar 09; 25(10):1463-73. PubMed ID: 16331273
    [Abstract] [Full Text] [Related]

  • 11. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
    Zhang D, Qiu L, Jin X, Guo Z, Guo C.
    Mol Cancer Res; 2009 Jul 09; 7(7):1139-49. PubMed ID: 19584264
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lipopolysaccharide and TNF-alpha activate the nuclear factor kappa B pathway in the human placental JEG-3 cells.
    Lappas M, Yee K, Permezel M, Rice GE.
    Placenta; 2006 Jul 09; 27(6-7):568-75. PubMed ID: 16122789
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bortezomib inhibits nuclear factor-kappaB dependent survival and has potent in vivo activity in mesothelioma.
    Sartore-Bianchi A, Gasparri F, Galvani A, Nici L, Darnowski JW, Barbone D, Fennell DA, Gaudino G, Porta C, Mutti L.
    Clin Cancer Res; 2007 Oct 01; 13(19):5942-51. PubMed ID: 17908991
    [Abstract] [Full Text] [Related]

  • 17. ERK and p38 MAP kinase are involved in downregulation of cell surface TNF receptor 1 induced by acetoxycycloheximide.
    Ogura H, Tsukumo Y, Sugimoto H, Igarashi M, Nagai K, Kataoka T.
    Int Immunopharmacol; 2008 Jun 01; 8(6):922-6. PubMed ID: 18442799
    [Abstract] [Full Text] [Related]

  • 18. Induction of high-molecular-weight (HMW) tumor necrosis factor(TNF) alpha by hepatitis C virus (HCV) non-structural protein 3 (NS3) in liver cells is AP-1 and NF-kappaB-dependent activation.
    Hassan M, Selimovic D, Ghozlan H, Abdel-Kader O.
    Cell Signal; 2007 Feb 01; 19(2):301-11. PubMed ID: 16916598
    [Abstract] [Full Text] [Related]

  • 19. Phosphorylation of extracellular signal-regulated kinase 1/2, p38 mitogen-activated protein kinase and nuclear translocation of nuclear factor-kappaB are involved in upregulation of matrix metalloproteinase-9 by tumour necrosis factor-alpha.
    Itatsu K, Sasaki M, Harada K, Yamaguchi J, Ikeda H, Sato Y, Ohta T, Sato H, Nagino M, Nimura Y, Nakanuma Y.
    Liver Int; 2009 Feb 01; 29(2):291-8. PubMed ID: 18710428
    [Abstract] [Full Text] [Related]

  • 20. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
    Mauro C, Zazzeroni F, Papa S, Bubici C, Franzoso G.
    Methods Mol Biol; 2009 Feb 01; 512():169-207. PubMed ID: 19347278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.